Kabra Drugs
KABRADGBSE

Kabra Drugs

₹31.000.63 (2.07%)1D
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events

Performance

Today’s low
30.00
Today’s high
31.50
52 week low
10.56
52 week high
35.52
Open price
30.37
Previous close
30.37
Live volume
42,438
Lower circuit
29.45
Upper circuit
32.55

Fundamentals

Market Cap
₹72Cr
ROE
4.59%
P/E Ratio(TTM)
16.78
EPS(TTM)
1.81
P/B Ratio
2.77
Dividend Yield
0.00%
Industry P/E
40.46
Book Value
10.96
Debt to Equity
0.02
Face Value
10

Financials

*All values are in Rs. Cr
No Graph Data To Display
Quarterly
Yearly

About

Kabra Drugs Limited is a public company established to operate in the pharmaceutical sector by manufacturing and trading pharma-related products. The company's future development is entirely dependent on the successful commencement of its operational activities. Due to a shortage of funds, the company could not perform any business activities during the year under review. In response, several cost-cutting measures have already been undertaken by the company to prepare for future operations. The Company believes that its human capital is its biggest asset and it greatly values its human resources. As part of its strategy, the company has planned to shift its registered office from Madhya Pradesh to Tamil Nadu.;
MD/CEO
N. ARAVIND
Founded in
1989
BSE symbol
524322

Shareholding Pattern

Dec '24
Mar '25
Jun '25
Sep '25
Dec '25
Retail And Others
100.00%

Similar stocks

StockMkt price (1D)52 week performanceMarket capP/E ratioP/B ratio
₹4,353.40
+12.40 (0.29%)
L
    H
    1,46,951.3264.6817.39
    Ajanta PharmaAJANTPHARM
    ₹2,974.90
    +58.60 (2.01%)
    L
      H
      36,434.3535.918.44
      ₹1,706.40
      -2.00 (0.12%)
      L
        H
        28,165.1133.252.95
        ₹1,069.20
        +64.90 (6.46%)
        L
          H
          21,286.9363.949.38
          2026
          13
          Feb
          Quarterly Result
          Release date
          2025
          13
          Nov
          Quarterly Result
          Release date
          14
          Aug
          Quarterly Result
          Release date
          30
          May
          Annual Result
          Release date
          14
          Feb
          Quarterly Result
          Release date
          2024
          14
          Nov
          Quarterly Result
          Release date
          14
          Aug
          Quarterly Result
          Release date
          30
          May
          Result
          Release date
          Events calendar
          View upcoming events in other stocks